Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

1.54USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$1.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
147,369
52-wk High
$11.41
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.469
Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 1.46
Year Ending Dec-19 3 0.00 0.00 0.00 4.40
Earnings (per share)
Quarter Ending Dec-18 4 -0.48 -0.37 -0.57 -0.97
Quarter Ending Mar-19 1 -0.42 -0.42 -0.42 --
Year Ending Dec-18 4 -2.09 -1.86 -2.31 -2.52
Year Ending Dec-19 4 -2.64 -1.59 -3.37 -2.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -- 0.63 0.87
Price to Sales (TTM) -- 109.82 6.55
Price to Book (MRQ) 2.02 13.72 4.00
Price to Tangible Book (MRQ) 2.03 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -- 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 52.63 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 5.59 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 4.63 5.52 2.99
LT Debt to Equity (MRQ) 50.11 15.33 11.31
Total Debt to Equity (MRQ) 67.73 18.80 14.15
Interest Coverage (TTM) -65.56 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -- -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -- -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -- -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,741,437 725,680,242
Net Income/Employee (TTM) -1,628,833 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.00 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -113.18 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) -145.42 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) -178.89 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 41.29%
# of Holders: 45
Total Shares Held: 5,890,396
3 Mo. Net Change: 1,382,950
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.